Skip to main content

Advertisement

Table 1 Demographic and medical characteristics

From: Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study

Variable Gout Asymptomatic hyperuricaemia Control
N 24 29 34
Gender, male, n (%) 24 (100 %) 29 (100 %) 34 (100 %)
Age, years, mean (SD) 58 (13) 58 (19) 58 (14)
Ethnicity, n (%) European 14 (58 %) European 24 (83 %) European 30 (88 %)
Maori 1 (4 %) Maori 0 (0 %) Maori 1 (3 %)
Pacific 5 (21 %) Pacific 3 (10 %) Pacific 0 (0 %)
Asian 4 (17 %) Asian 2 (7 %) Asian 3 (9 %)
BMI, kg/m2, mean (SD) 30.2 (4.0)* 29.3 (5.9)* 25.0 (2.9)
Diuretic use, n (%) 3 (12 %) 7 (24 %) 4 (12 %)
NSAID use, n (%) 14 (58 %)* 11 (38 %) 7 (21 %)
Prednisone use, n (%) 5 (21 %) 0 (0 %) 0 (0 %)
Hypertension, n (%) 17 (70 %)* 16 (55 %)* 9 (26 %)
Cardiovascular disease, n (%) 7 (29 %)* 5 (17 %) 1 (3 %)
Diabetes, n (%) 4 (17 %) 1 (3 %) 2 (6 %)
Urate, mmol/l Mean (SD) 0.35 (0.10) 0.46 (0.05)* 0.32 (0.06)
Range 0.24 - 0.63 0.41 - 0.63 0.20 - 0.40
1MTPJ tenderness, n (%) Right 4 (17 %) 1 (0 %) 0 (0 %)
Left 3 (12 %) 0 (0 %) 1 (3 %)
1MTPJ swelling, n (%) Right 1 (4 %) 0 (0 %) 0 (0 %)
Left 0 (0 %) 0 (0 %) 0 (0 %)
66/68 joint count, mean (SD) Tender 2.7 (6.1)* 1.5 (1.9) 0.6 (1.2)
Swollen 1.0 (1.7)* 0.2 (0.7) 0.0 (0.0)
  1. *Significantly different from controls (p < 0.05)